Related Experiment Video
Updated: Dec 20, 2025

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Low prevalence and disease severity of COVID-19 in post-liver transplant recipients-A single centre experience
Anita Verma1, Shirin Elizabeth Khorsandi1, Annalisa Dolcet1
1Institute of Liver Studies, King's College Hospital, London, UK.
Insights
Liver transplant recipients show a low incidence of COVID-19 with less severe symptoms than expected. This may be due to adherence to self-isolation and optimal immunosuppression levels modulating the immune response.
Area of Science:
- Hepatology
- Transplant Surgery
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) poses a significant risk to immunosuppressed individuals.
- Liver transplant recipients represent a vulnerable population during the COVID-19 pandemic.
- Understanding COVID-19's impact on this cohort is crucial for patient management.
Purpose of the Study:
- To report on the incidence and severity of COVID-19 in liver transplant recipients.
- To compare outcomes in liver transplant recipients with the general population and other solid organ recipients.
- To explore potential factors influencing COVID-19 outcomes in this group.
Main Methods:
- Retrospective analysis of COVID-19 cases in liver transplant recipients (n=5).
- Data collected from a high-volume UK liver transplant unit.
- Comparison with a larger follow-up cohort (n=4500) and general population data.
Main Results:
- A low incidence of COVID-19 was observed among liver transplant recipients.
- Symptoms appeared less severe than anticipated when compared to other groups.
- No specific details on symptom severity or outcomes were provided for the 5 cases.
Conclusions:
- Liver transplant recipients may experience a lower incidence and severity of COVID-19.
- Potential protective factors include strict adherence to self-isolation and an 'ideal' level of immunosuppression.
- Further research with larger cohorts is needed to confirm these preliminary findings.
Abstract:
Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is driving a present day global pandemic. Immunosuppressed patients are regarded as a high-risk cohort. The following is a short report on COVID-19 in liver transplant recipients (n = 5) from a high volume UK liver transplant unit with a large follow-up cohort (n = 4500). Based on this limited data, liver transplant recipients appear to have a low incidence of COVID-19, with less severe symptoms than expected, when compared with the general population and other solid organ recipients. This possibly could be related to self-isolation adherence and/or the 'ideal' level of immunosuppression that favourably modulates the immune response to COVID-19.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management

